Evidence map›Paper›PMID 21686224›Full record

ArticleTransactions of the American Clinical and Climatological Association2011

Out on a LIM: chronic kidney disease, podocyte phenotype and the Wilm's tumor interacting protein (WTIP).

John R Sedor, Sethu M Madhavan, Jane H Kim, Martha Konieczkowski

Open access · greenAbstract read
In one paragraph

Article in Transactions of the American Clinical and Climatological Association, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Role of protein phosphatase 2A in kidney disease (Review).Experimental and therapeutic medicine · 2021
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

John R Sedorjohn.sedor@case.edu
Sethu M Madhavan
Jane H Kim
Martha Konieczkowski

Funding

CWRU NEPHROLOGY TRAINING PROGRAMT32DK007470 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI SEDOR, JOHN R. · 1986 to 2019
$2.9M
TARGETING RENAL OUTER MEDULLARY K+ CHANNEL ROMK FOR NEW CLASS OF DIURETICSP50DK054178 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI SEDOR, JOHN R. · 1998 to 2002
$2.2M
Mechanisms of Glomerular ScarringR01DK064719 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI SEDOR, JOHN R. · 2003 to 2006
$1.2M
The WT1 Interacting Protein: a choreographer of morphology and transcriptionF30DK083897 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI KIM, JANE · 2009 to 2012
$141k
NIDDK NIH HHS DK-064719NIDDK NIH HHS DK-07470NIDDK NIH HHS F30 DK083897NIDDK NIH HHS P50 DK-054178NIDDK NIH HHS R01 DK064719NIDDK NIH HHS T32 DK007470
6 · The paper itself

Abstract

Normal function of the glomerular filtration barrier requires wild-type differentiation of the highly specialized glomerular epithelial cell, the podocyte. Podocytes express three distinct domains, consisting of a cell body, primary processes, and secondary foot processes (FP). These FP express slit diaphragms, which are highly specialized cell-cell contacts critical for filtration-barrier function. Foot processes are dynamic structures that reorganize within minutes through actin cytoskeletal rearrangement. Glomerular diseases are characterized by a persistent simplification in podocyte domain structure with loss of FP, a phenotype described as FP effacement. The generation of such phenotypic plasticity requires that signaling pathways in subcellular compartments be integrated dynamically for a cell to respond appropriately to information flow from its microenvironment. We have identified a LIM-domain-containing protein, Wilm's tumor interacting protein (WTIP), that regulates podocyte actin dynamics to maintain stable cell contacts. After glomerular injury, the WTIP molecule shuttles to the podocyte nucleus in response to changes in slit-diaphragm assembly, and changes gene transcription to permit podocyte remodeling. Defining regulatory pathways of podocyte differentiation identifies novel, druggable targets for chronic kidney diseases characterized by glomerular scarring.

Indexed as

AnimalsCarrier ProteinsChronic DiseaseCo-Repressor ProteinsCytoskeletal ProteinsGlomerular Filtration RateHumansKidney DiseasesMiceMice, TransgenicPhenotypePodocytesProteinuriaSignal TransductionWT1 ProteinsCarrier ProteinsCo-Repressor ProteinsCytoskeletal ProteinsWT1 ProteinsWTIP protein, human

Identifiers

PMID21686224
PMCPMC3116355
OpenAlexW1449142897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.